GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Solventum Corporation
Solventum Corporation, a healthcare spinoff from 3M, focuses on medical technologies. Its initial share price reflects investors' assessment of the prospects for a standalone business in areas such as wound care, filtration, and healthcare software.
Share prices of companies in the market segment - Treatment
Solventum, a spinoff from 3M, operates in four healthcare segments: medical surgery, dentistry, filtration, and health technologies. We classify it as part of the treatment sector. The chart below shows the overall dynamics of this diversified medical market.
Broad Market Index - GURU.Markets
Solventum is a 3M spinoff focused exclusively on healthcare products, from medical supplies to IT solutions. As a major new player, it is included in the GURU.Markets index. The chart below shows the overall market performance. Compare its stock performance to the overall healthcare sector.
Change in the price of a company, segment, and market as a whole per day
SOLV - Daily change in the company's share price Solventum Corporation
For Solventum, a healthcare company spun off from 3M, daily price changes are a measure of its response to medical trends. The graph of these fluctuations is unspectacular, but it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Treatment
Solventum Corporation is a 3M spinoff focused on healthcare. This chart shows the average daily volatility of the sector. Comparison with SOLV's performance helps assess the extent to which its medical product portfolio makes it more or less sensitive to industry risks.
Daily change in the price of a broad market stock, index - GURU.Markets
Solventum, a spinoff from 3M, is a healthcare company focused on medical technologies, from wound care to dentistry. The chart below shows general market fluctuations, which can be used to assess how the healthcare sector, represented by Solventum, is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Solventum Corporation
Solventum, a spinoff from 3M, is now a medical technology company. Its year-over-year performance reflects robust demand for its wound care and oral hygiene products, as well as its new strategy as an independent company.
Annual dynamics of market capitalization of the market segment - Treatment
Solventum Corporation, recently spun off from 3M, is a global medical technology company. Its businesses include wound care, dentistry, and filtration. The chart below shows how investors view the prospects of this new, healthcare-focused company compared to its former industrial parent.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Solventum is a healthcare technology company spun off from 3M. Its business focuses on medical solutions, from wound care to filtration. Stable demand for its products makes it a safe haven asset, its performance unaffected by economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Solventum Corporation
Solventum, a healthcare company spun off from 3M, has a market capitalization that reflects demand for its medical products. Monthly fluctuations in the chart depend on the volume of elective surgical procedures and demand for its wound care and hygiene solutions, which ensures relatively stable cash flow.
Monthly dynamics of market capitalization of the market segment - Treatment
This chart shows the dynamics of the healthcare sector. For Solventum, recently spun off from 3M, this provides context. Its movements reflect demand for its wide range of medical products, from wound dressings to software, against the backdrop of overall industry trends.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Solventum is a healthcare business spun off from 3M. Shares of such companies often perform strongly after a split, as investors see a more focused story. The chart below allows you to assess how this corporate story influenced the stock, regardless of overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Solventum Corporation
Short-term fluctuations in Solventum, a healthcare company spun off from 3M, reflect medical sector news. Data on the number of surgical procedures, demand for dressings, and innovations in dentistry shape the weekly performance of this new market player.
Weekly dynamics of market capitalization of the market segment - Treatment
Solventum shares, like those of the entire medical technology sector, respond to general trends in healthcare. Surgical procedure volumes and hospital budgets are key drivers for everyone. The chart will show how the 3M spinoff competes in this established market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Solventum, spun off from 3M, specializes in healthcare products. This sector is considered "defensive." The chart will show whether the new company's shares are indeed less volatile than the market due to stable demand for medical products.
Market capitalization of the company, segment and market as a whole
SOLV - Market capitalization of the company Solventum Corporation
Solventum's market capitalization chart is the financial history of a new company spun off from 3M and focused exclusively on healthcare. It reflects investor valuations of its portfolio of well-known wound care, dental, and filtration products. Its initial dynamics represent the market's attempt to determine the fair value of this business as an independent entity.
SOLV - Share of the company's market capitalization Solventum Corporation within the market segment - Treatment
Solventum Corporation, a spinoff from 3M, is a company focused on healthcare products. Its share of the medical technology sector's market capitalization reflects its legacy and portfolio of established brands, such as Tegaderm. The chart shows its weight as a new independent player.
Market capitalization of the market segment - Treatment
Solventum was spun off from 3M, integrating its healthcare business. The chart below shows the overall market capitalization of the healthcare sector. It reflects the scale of the industry, in which Solventum is now a major independent player with well-known brands and a long history of innovation.
Market capitalization of all companies included in a broad market index - GURU.Markets
New companies are sometimes born within the large conglomerates visible on the chart. Solventum was spun off from 3M and is focusing on healthcare. Its market capitalization is a measure of its medical product portfolio and its ability to grow as an independent company.
Book value capitalization of the company, segment and market as a whole
SOLV - Book value capitalization of the company Solventum Corporation
The book value of Solventum, a new company spun off from 3M, represents a legacy asset in the healthcare sector. The chart reflects the value of factories, laboratories, and equipment used to manufacture medical devices, from adhesive bandages to complex surgical instruments.
SOLV - Share of the company's book capitalization Solventum Corporation within the market segment - Treatment
Solventum, a healthcare company spun off from 3M, inherited significant manufacturing assets. Its stake in the sector includes factories producing medical devices, from adhesive bandages to filtration systems. This material base ensures its widespread presence in hospitals worldwide.
Market segment balance sheet capitalization - Treatment
Solventum, a spinoff from 3M, focuses on medical technologies. Their business, inherited from the parent company, relies on significant production capacity and R&D centers to create everything from bandages to software. The book value chart will reveal this "heavy" material base.
Book value of all companies included in the broad market index - GURU.Markets
Solventum, a healthcare company spun off from 3M, owns factories producing medical products, from bandages to hospital software. The chart below shows how this new giant's inventory will develop.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Solventum Corporation
Solventum, a new company spun off from 3M, owns medical equipment factories. The chart will show how the market will evaluate its ability to operate as an independent company and what premium it will place on its renowned brands and patents.
Market to book capitalization ratio in a market segment - Treatment
Solventum, a healthcare spinoff from 3M, produces medical devices and software. Its value lies in its product portfolio, patents, and relationships with hospitals. The chart shows how the market values ββthese assets and future growth prospects relative to its book value.
Market to book capitalization ratio for the market as a whole
Solventum, a spinoff from 3M, is a healthcare-focused company. Its portfolio includes wound care, dental, and filtration solutions. The company's valuation, relative to the market average, will be determined by the strength of its brands, innovative potential, and ability to operate effectively as an independent organization in the competitive healthcare industry.
Debts of the company, segment and market as a whole
SOLV - Company debts Solventum Corporation
Solventum was spun off from 3M as an independent healthcare company. This chart reflects its initial financial structure. The company begins its history with a certain level of debt, which it will seek to optimize by relying on cash flows from its established medical device and solutions businesses.
Market segment debts - Treatment
Solventum, recently spun off from 3M, is focused exclusively on the healthcare business. The company inherits strong brands and technologies, but now must build its own financial story. This chart shows how the newly independent company is shaping its debt policy to compete in the medical device market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Solventum Corporation
Solventum was spun off from 3M and manufactures medical devices and technologies. This chart shows its initial debt load as an independent company. It must prove its ability to generate stable cash flow to service its debt and invest in R&D in a competitive healthcare market.
Market segment debt to market segment book capitalization - Treatment
Solventum, spun off from 3M, focuses on medical technologies, including wound care, dentistry, and filtration. This sector requires ongoing investment in R&D and clinical trials. The chart shows the overall debt load in the medical device industry, which helps assess the financial position of the newly independent company.
Debt to book value of all companies in the market
Solventum, spun off from 3M, operates in the medical technology sector. This chart shows the average debt level across the economy. It allows one to compare the newly independent company's financial policies with overall stock market trends, not just those in the healthcare sector.
P/E of the company, segment and market as a whole
P/E - Solventum Corporation
Solventum was spun off from 3M, combining its medical businesses, including wound dressings, hygiene solutions, and healthcare software. This chart shows how investors value the new, medical-focused company. The performance will reflect its ability to grow faster and be more innovative than it was as part of the conglomerate.
P/E of the market segment - Treatment
Solventum Corporation, spun off from 3M, is focused on healthcare. The company produces a wide range of products, from medical tapes and bandages to hospital software. This chart shows the average valuation for the healthcare sector, allowing investors to gauge the prospects of this new independent player.
P/E of the market as a whole
Solventum, a spinoff from 3M, focuses on healthcare businesses, including medical supplies and software. This chart shows general trends in the healthcare sector. Solventum is sensitive to demographic trends and the volume of elective medical procedures. The company's valuation reflects the stability and predictability of this market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Solventum Corporation
Solventum was spun off from 3M, integrating its healthcare businesses. The company produces a wide range of medical products, from wound dressings to hospital software. This chart reflects expectations for the stability and growth of the healthcare sector. Its dynamics forecast demand for products essential to the daily operations of healthcare facilities.
Future (projected) P/E of the market segment - Treatment
Solventum, a spinoff from 3M, is a global healthcare company focused on medical technology, dentistry, and cleaning. This chart shows the company's estimated future revenue in the context of the healthcare sector. It highlights investors' initial expectations for the newly independent company and its growth potential.
Future (projected) P/E of the market as a whole
Solventum, spun off from 3M, is a company focused on healthcare products, including medical consumables and cleaning solutions. This graph of overall market expectations is important for Solventum, but their business is defensive. Demand for their products in hospitals and clinics is relatively stable and driven by the number of procedures, not the state of the economy.
Profit of the company, segment and market as a whole
Company profit Solventum Corporation
Solventum is a company spun out of 3M, integrating its healthcare businesses. It specializes in medical technologies, including wound care, dentistry, and filtration systems. This chart shows the financial results of a focused player built on a scientific heritage and medical innovation.
Profit of companies in the market segment - Treatment
Solventum, spun off from 3M, focuses on healthcare businesses, including medical devices and software. This chart shows profitability in the medical technology sector. For SOLV, this reflects global healthcare trends, such as an aging population and the need for more effective medical solutions, which drives stable demand.
Overall market profit
Solventum was spun off from 3M, integrating its healthcare business. The company produces a wide range of medical products, from wound dressings to hospital software. Demand for healthcare products is generally stable and unaffected by economic cycles. This chart compares Solventum's protective nature with the volatility of the industrial sector.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Solventum Corporation
Solventum, spun off from 3M, is a global healthcare company. The earnings forecast presented here reflects expectations for its four segments: medical surgery, dental care, information systems, and cleaning. Analysts assess the newly independent company's ability to focus and grow in its core markets.
Future (predicted) profit of companies in the market segment - Treatment
Solventum, a spinoff from 3M, is a company focused on healthcare products and technologies. The revenue forecast for this sector depends on the volume of elective medical procedures and innovation. This chart reflects analyst expectations for future demand for medical supplies, wound healing systems, and healthcare software.
Future (predicted) profit of the market as a whole
Solventum, a spinoff from 3M, focuses on medical technologies, including wound care and oral health systems. The company's business is relatively stable but dependent on healthcare system budgets. The total revenue projections shown here provide context for assessing the financial health of these systems worldwide.
P/S of the company, segment and market as a whole
P/S - Solventum Corporation
Solventum Corporation, a spinoff from 3M, specializes in medical technologies. This chart shows the market's initial estimate of its revenue, which is generated by selling a wide range of healthcare products. Investors are assessing its ability to operate as an independent company and realize the potential of its established brands.
P/S market segment - Treatment
Solventum, a spinoff from 3M, is a global healthcare company specializing in medical supplies, dental care, and filtration systems. This chart shows the average revenue estimate for the medical equipment sector. It provides insight into how investors view Solventum's portfolio of well-known brands and its potential as a standalone company.
P/S of the market as a whole
Solventum was spun off from 3M, consolidating its healthcare businesses. The company produces a wide range of medical products, from wound dressings to hospital software. This chart provides a market-wide perspective for assessing investor sentiment on revenue prospects in the diversified and large medical technology sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Solventum Corporation
Solventum, a spinoff from 3M, is a global healthcare company specializing in medical technologies and wound care solutions. This chart shows how investors estimate the company's future revenue. It reflects expectations for demand for medical devices and innovations in this field.
Future (projected) P/S of the market segment - Treatment
Solventum Corporation was spun off from 3M and focuses on the healthcare business. Its portfolio includes medical supplies, healthcare software, and cleaning technologies. This chart reflects investor expectations for this new, more healthcare-focused company and its ability to grow independently.
Future (projected) P/S of the market as a whole
Solventum, a spinoff from 3M, is a company focused on healthcare technologies, including wound care and filtration systems. Demand for their products depends on the volume of medical procedures. This schedule, reflecting economic stability, is important. It ensures stable funding for hospitals, which are their key customers and purchase their products.
Sales of the company, segment and market as a whole
Company sales Solventum Corporation
Solventum was spun off from 3M, integrating its healthcare businesses. The company produces a wide range of medical products, from wound dressings to hospital software. This graph reflects demand for medical products and services. Revenue dynamics depend on the volume of elective surgeries, product innovations, and healthcare system budgets.
Sales of companies in the market segment - Treatment
Solventum is a new company spun off from 3M, focused entirely on the healthcare business. It encompasses medical solutions, from wound dressings and surgical instruments to healthcare software. Its revenue structure reflects the contribution of each of these legacy and innovative medical businesses.
Overall market sales
Solventum, a spinoff from 3M, is a healthcare-focused company. It produces a wide range of products, from medical dressings and surgical supplies to hospital software. This total revenue chart includes the vast healthcare market, where Solventum is a major and diversified player.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Solventum Corporation
Solventum Corporation was spun off from 3M and integrates its healthcare business. The company produces a wide range of medical products, from wound dressings to software. This chart reflects revenue forecasts, which are driven by surgical procedure volumes and demand for medical supplies in hospitals.
Future (projected) sales of companies in the market segment - Treatment
Solventum, a spinoff from 3M, is a global healthcare company specializing in medical technology, dentistry, and cleaning systems. This chart shows forecasts for the entire medical device and solutions market. It reflects expectations for growth in global healthcare spending, a key driver of Solventum's business.
Future (projected) sales of the market as a whole
Solventum, a healthcare spinoff from 3M, produces medical devices and software. This chart, which reflects healthcare spending forecasts, is important to the company. Economic stability provides funding for hospitals and clinics, allowing them to purchase Solventum's advanced products to improve patient care and increase efficiency.
Marginality of the company, segment and market as a whole
Company marginality Solventum Corporation
Solventum, a healthcare spinoff from 3M, shows its profitability in this chart. Its profitability is built on sales of a wide range of medical products, from wound dressings to hospital software. Strong brands and innovative, market-leading products are the foundation of its financial stability.
Market segment marginality - Treatment
Solventum Corporation, a spinoff of 3M, is a global healthcare company specializing in medical technology, dentistry, and cleaning systems. Profitability depends on product innovation and strong relationships with the medical community. This chart shows the operating efficiency of its legacy portfolio. A comparison with the industry highlights its position.
Market marginality as a whole
Solventum, spun off from 3M, is a healthcare technology company focused on medical supplies, hospital IT solutions, and cleaning systems. Demand in this sector is stable and non-cyclical. This gross margin chart highlights the defensive nature of Solventum's business.
Employees in the company, segment and market as a whole
Number of employees in the company Solventum Corporation
Solventum is a recently spun-off healthcare business from 3M. The company inherited a rich heritage of innovation and established brands in areas such as medical dressings, dentistry, and healthcare software. This graph shows a large team now focused exclusively on solving medical problems.
Share of the company's employees Solventum Corporation within the market segment - Treatment
Solventum was spun off from 3M, integrating its healthcare business. The company is a major player in areas such as medical solutions, oral hygiene, and filtration systems. This chart illustrates its scale as an emerging but already established giant. It reflects the significant share of scientists and engineers in medical technology that Solventum occupies.
Number of employees in the market segment - Treatment
Solventum was spun off from 3M, integrating its medical business. The company is a major player in medical technology, from wound dressings to healthcare software. This chart shows the vast team of specialists inherited from 3M, who continue to develop and manufacture products to improve patient health.
Number of employees in the market as a whole
Solventum Corporation, a spinoff from 3M, is a global healthcare company specializing in medical technology, cleaning, and dentistry. Demand for its products is driven by the volume of medical procedures and healthcare spending. The growth in overall employment seen in this chart supports the health insurance system, ensuring patients have access to procedures that utilize Solventum products.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Solventum Corporation (SOLV)
Solventum, spun off from 3M, focuses on healthcare products. This chart illustrates a business built on science and brands. The moderate capitalization per employee reflects the balance between the value of patents and established products and the need to maintain global manufacturing and a sales team to serve healthcare institutions.
Market capitalization per employee (in thousands of dollars) in the market segment - Treatment
Solventum (SOLV) is a recently spun-off healthcare business from 3M (wound care, dentistry, filtration). As a new company, it has established brands and a large workforce. This chart shows the industry average. Comparisons with this average will help investors understand how the market views the performance of this new but mature player in the medtech sector.
Market capitalization per employee (in thousands of dollars) for the overall market
Solventum, a spinoff from 3M, is a healthcare technology company. For such a company, this metric reflects the value of its patent portfolio and brands (e.g., Tegaderm). It also reflects how the market values ββthe company's ability to create innovative medical products that generate high profits.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Solventum Corporation (SOLV)
Solventum is a recently spun-off healthcare business from 3M (wound care, dentistry, software). This chart will reflect the performance of a mature, high-margin healthcare business. The company inherited strong brands and technologies. Its profitability per employee will be determined by the strength of these brands and the ability of its R&D team to introduce new products.
Profit per employee (in thousands of dollars) in the market segment - Treatment
Solventum (SOLV) is a "medical" business spun off from 3M (Tegaderm bandages, dentistry). This chart shows the benchmark for "Treatment." In this sector (CPG for hospitals), the benchmark is high. Profits are generated by the strength of a "trusted" brand and patents on "consumables" that hospitals regularly purchase.
Profit per employee (in thousands of dollars) for the market as a whole
Solventum, a spinoff from 3M, is a global healthcare company focused on medical technologies. This productivity profile demonstrates the research-intensive nature of their business. Developing innovative materials for wound care or dentistry requires a team of scientists whose work creates products with high added value and profitability.
Sales to employees of the company, segment and market as a whole
Sales per company employee Solventum Corporation (SOLV)
Solventum was spun off from 3M and is focusing on medical technologies. This chart will demonstrate its ability to operate as an independent company. High revenue per employee is expected to reflect the value of its product portfolio, including wound care, hygiene, and filtration solutions, which have a strong position in the healthcare market.
Sales per employee in the market segment - Treatment
Solventum is the new name for 3M's healthcare business, which has been spun off into a separate company. They produce a wide range of medical devices, from bandages to software. This chart shows how efficient their diversified healthcare business is, comparing how their staff generates revenue compared to other medtech players.
Sales per employee for the market as a whole
Solventum is a new name for an old business: the medical division recently spun off from 3M. They produce a wide range of medical devices, from adhesives and wound care solutions to dental materials and hospital software. This chart shows the revenue generated by this diversified medical portfolio.
Short shares by company, segment and market as a whole
Shares shorted by company Solventum Corporation (SOLV)
Solventum (SOLV) is a company recently spun off from 3M, which consolidated all of 3M's healthcare businesses (medical supplies, software, and cleaning products). This chart shows bearish bets. The increase in shorts on the new company may reflect investor skepticism about its growth prospects without 3M's backing or concerns about legacy liabilities.
Shares shorted by market segment - Treatment
Solventum (SOLV) is a recently spun-off healthcare business from 3M, specializing in medical technology, dentistry, and cleaning. This chart reflects the overall sentiment in the medical technology sector, showing how many investors expect a downturn in the industry or are skeptical of the new independent company's prospects.
Shares shorted by the overall market
Solventum (SOLV) is a recent spinoff from 3M focused exclusively on healthcare technologies. This chart measures the overall level of market fear. When pessimism rises, investors often seek "safe haven" sectors. Healthcare is one such sector. The question is, will the market perceive the new company, SOLV, as a safe haven or a risky asset without a long history?
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Solventum Corporation (SOLV)
Solventum is a recently spun-off healthcare business from 3M. The company focuses on medical equipment, dentistry, and healthcare software. The chart reflects the market's attempts to find a "fair" price: periods of optimism (above 70) about its independence and pessimism (below 30) due to legacy problems, debt burden, and competition.
RSI 14 Market Segment - Treatment
Solventum is a healthcare business recently spun off from 3M (MMM). The company is a global leader in advanced wound care solutions, dental materials, and health IT software. This chart shows the overall sentiment in the medical technology sector, helping to assess how the market views this newly independent industry giant.
RSI 14 for the overall market
Solventum is a recently spun-off healthcare business from 3M, specializing in wound care, dentistry, and medical information systems. It's a stable yet mature segment. This market sentiment indicator suggests that during periods of panic (low values), investors may consider SOLV a "defensive" stock. Demand for its medical supplies is largely independent of the economic climate.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SOLV (Solventum Corporation)
Solventum Corporation is a spinoff from 3M focused exclusively on healthcare technologies (medical supplies, health software). This chart reflects analyst expectations. Their forecasts are based on the company's ability to grow as an independent entity, manage costs, and drive innovation in the medical technology sector.
The difference between the consensus estimate and the actual stock price SOLV (Solventum Corporation)
Solventum is a healthcare business recently spun off from 3M. The company specializes in wound care, dental products, and healthcare software. This chart shows the difference between the consensus estimate and the price. It reflects whether analysts believe Solventum (as an independent company) can grow more effectively than it did within 3M.
Analyst consensus forecast for stock prices by market segment - Treatment
Solventum is the former healthcare division of 3M, spun off into a separate business. The company produces a wide range of medical products, from adhesive bandages to dental materials. This chart shows analysts' overall expectations for the entire medical supplies sector, reflecting whether experts believe demand will remain stable.
Analysts' consensus forecast for the overall market share price
Solventum is a company spun off from 3M, incorporating the company's entire medical business (wound care, dentistry, and healthcare software). It's a stable sector. However, overall market expectations, as shown in this chart, impact hospital budgets. During a downturn, clinics may postpone purchasing consumables or switch to cheaper alternatives.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Solventum Corporation
Solventum is a recently spun-off healthcare business from 3M. Their portfolio includes advanced wound care solutions, surgical supplies, and dental software. This chart is an assessment of the new business. It reflects the stable demand for their medical consumables and the company's ability to operate as an independent, focused entity.
AKIMA Market Segment Index - Treatment
Solventum (spinned off from 3M) is 3M's new pure-play medical business; the company owns a portfolio of brands in surgery, dentistry, and filtration. This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does Solventum's diversified medical portfolio differentiate it from the average competitor?
The AKIM Index for the overall market
Solventum is a healthcare business (medical, surgical, and oral hygiene) spun off from 3M. It's a mature, stable business. This chart, showing the market average, provides context. It helps assess how this protective equipment company, spun off from an industrial giant, stacks up against the broader macroeconomic fluctuations reflected by this indicator.